Compare BAM & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAM | ELV |
|---|---|---|
| Founded | 2022 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7B | 80.9B |
| IPO Year | 2022 | 2001 |
| Metric | BAM | ELV |
|---|---|---|
| Price | $48.10 | $385.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 19 |
| Target Price | $60.83 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 2.0M | 1.6M |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.94% | 1.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 14.73 |
| Revenue | $4,817,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $29.89 | N/A |
| Revenue Next Year | $14.70 | $3.07 |
| P/E Ratio | $34.43 | ★ $25.69 |
| Revenue Growth | ★ 21.03 | 12.49 |
| 52 Week Low | $42.20 | $273.71 |
| 52 Week High | $64.10 | $436.24 |
| Indicator | BAM | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 55.32 | 45.76 |
| Support Level | $46.10 | $382.77 |
| Resistance Level | $49.90 | $408.00 |
| Average True Range (ATR) | 1.17 | 13.32 |
| MACD | 0.05 | -2.80 |
| Stochastic Oscillator | 62.76 | 29.50 |
Brookfield Asset Management is one of the world's largest alternative-asset managers, with USD 1.181 trillion in total managed assets, including USD 602.7 billion in fee-earning AUM, at the end of 2025. The company has three main business segments: credit strategies (USD 363.0 billion in total AUM and USD 279.4 billion in fee-earning AUM), private equity (USD 155.0 billion/USD 48.0 billion), and real estate/real assets (USD 663.0 billion/USD 275.3 billion). The firm primarily serves institutional investors (90% of AUM) and high-net-worth individuals (10%), and is diversified globally, with 67% of revenue from the Americas, 20% from EMEA, and 13% from Asia-Pacific. Canada-based Brookfield Corp. owns 73% of Brookfield's outstanding Class A shares.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.